BIIB

NASDAQ · Biotechnology

Biogen Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$207.94

+1.66 (+0.80%)

As of Aug 9, 9:36 PM ET ·

Analyst Consensus

Buy

Analysts

Very High

Coverage

Buy 29 67%

Hold 13 30%

Sell 1 2%

Price Target

Analyst Price Target -56.0% upside

Low Target $57.23

Average Target $91.45

High Target $114.90

Current Price $207.94

Current
$207.94

Target
$91.45

$57.23 $91.45 avg $114.90

Scenario Analysis

Bear Case

$57.23

-72.5%

Low target

Base Case

$91.45

-56.0%

Avg target

Bull Case

$114.90

+-44.7%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$219.72

-5.4% from high

52-Week Low

$127.00

+63.7% from low

50-Day SMA

$179.51

+15.8% vs SMA

200-Day SMA

$150.33

+38.3% vs SMA

RSI (14)

64.3

Neutral

Target vs 52W High

$91.45

-58.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%